Plasma levels of 8-methoxypsoralen following oral or bath-water treatment
- 1 July 1991
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 125 (1) , 56-58
- https://doi.org/10.1111/j.1365-2133.1991.tb06040.x
Abstract
The plasma levels of 8-methoxypsoralen (8-MOP) were determined in 18 patients on PUVA treatment for their psoriasis and in two control volunteers. Seven of the patients were on oral therapy and 13 having bath treatment. The plasma levels of 8-MOP were determined up to 6 h after treatment and varied between less than 10 ng/ml and 360 ng/ml for the orally treated group, and in the bath-treatment group were all less than 10 ng/ml.Keywords
This publication has 17 references indexed in Scilit:
- Bath PUVA for psoriasis: the West Midlands experienceBritish Journal of Dermatology, 1990
- Side-effects of psoralen photochemotherapy (PUVA)British Journal of Dermatology, 1990
- Plasma levels of 8-methoxypsoralen in psoriatic patients receiving topical 8-methoxypsoralenBritish Journal of Dermatology, 1982
- Keratoses and nonmelanoma skin tumors in long-term photochemotherapy (PUVA)Journal of the American Academy of Dermatology, 1980
- Pharmacokinetic and clinical comparison of two 8-methoxypsoralen brandsArchives of Dermatological Research, 1980
- Plasma Levels of 8-Methoxypsoralen Determined by High-Pressure Liquid Chromatography in Psoriatic Patients Ingesting Drug from Two ManufacturersJournal of Investigative Dermatology, 1980
- 8-MOP plasma levels in PUVA problem cases with psoriasisBritish Journal of Dermatology, 1979
- Serum levels of 8-methoxypsoralen in psoriasis patients using a new fluorodensitometric methodArchives of Dermatological Research, 1978
- Topical methoxsalen and blacklight in the treatment of psoriasisArchives of Dermatology, 1977
- Serum level profiles of 8-methoxypsoralen after oral administrationArchives of Dermatological Research, 1977